Joanne Potterton1, Aimee Stewart, Peter Cooper, Pieter Becker. 1. Department of Physiotherapy, University of the Witwatersrand, and Charlotte Maxeke Johannesburg Hospital, Johannesburg, South Africa. joanne.potterton@wits.ac.za
Abstract
AIMS: The human immunodeficiency virus (HIV) potentially causes a significant encephalopathy and resultant developmental delay in infected children. The aim of this study was to determine whether a home-based intervention programme could have an impact on the neurodevelopmental status of children infected with HIV. METHOD: A longitudinal, randomized, controlled trial was conducted. A total of 122 children aged less than 2 years 6 months were assigned to either a comparison or an experimental group. Children in the experimental group were given a home stimulation programme that was updated every 3 months. The home programme included activities to promote motor, cognitive, and speech and language development. Children in the comparison group received no developmental intervention. Children were assessed by a blinded assessor at baseline, 6 months, and 12 months using the Bayley Scales of Infant Development, 2nd edition. RESULTS: The children in this study came from poor socioeconomic backgrounds and their nutritional status was suboptimal. The experimental group included 60 children (30 males, 30 females) with a mean age of 18 months (SD 8.1 mo). The comparison group included 62 children (32 males, 30 females) with a mean age 19 months (SD 8.2 mo). Cognitive and motor development were severely affected at baseline, with 52% of the children having severe cognitive delay and 72% having severe motor delay at baseline. Children in the experimental group showed significantly greater improvement in cognitive (p=0.010) and motor (p=0.020) development over time than children in the comparison group. INTERPRETATION: A home stimulation programme taught to the caregiver can significantly improve cognitive and motor development in young children infected with HIV.
RCT Entities:
AIMS: The human immunodeficiency virus (HIV) potentially causes a significant encephalopathy and resultant developmental delay in infected children. The aim of this study was to determine whether a home-based intervention programme could have an impact on the neurodevelopmental status of children infected with HIV. METHOD: A longitudinal, randomized, controlled trial was conducted. A total of 122 children aged less than 2 years 6 months were assigned to either a comparison or an experimental group. Children in the experimental group were given a home stimulation programme that was updated every 3 months. The home programme included activities to promote motor, cognitive, and speech and language development. Children in the comparison group received no developmental intervention. Children were assessed by a blinded assessor at baseline, 6 months, and 12 months using the Bayley Scales of Infant Development, 2nd edition. RESULTS: The children in this study came from poor socioeconomic backgrounds and their nutritional status was suboptimal. The experimental group included 60 children (30 males, 30 females) with a mean age of 18 months (SD 8.1 mo). The comparison group included 62 children (32 males, 30 females) with a mean age 19 months (SD 8.2 mo). Cognitive and motor development were severely affected at baseline, with 52% of the children having severe cognitive delay and 72% having severe motor delay at baseline. Children in the experimental group showed significantly greater improvement in cognitive (p=0.010) and motor (p=0.020) development over time than children in the comparison group. INTERPRETATION: A home stimulation programme taught to the caregiver can significantly improve cognitive and motor development in young children infected with HIV.
Authors: Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Joseph Kagaayi; Godfrey Kigozi; David Serwadda; Avy Violari; Ronald H Gray Journal: J Acquir Immune Defic Syndr Date: 2017-05-01 Impact factor: 3.731
Authors: John P Elder; Willo Pequegnat; Saifuddin Ahmed; Gretchen Bachman; Merry Bullock; Waldemar A Carlo; Venkatraman Chandra-Mouli; Nathan A Fox; Sara Harkness; Gillian Huebner; Joan Lombardi; Velma McBride Murry; Allisyn Moran; Maureen Norton; Jennifer Mulik; Will Parks; Helen H Raikes; Joseph Smyser; Caroline Sugg; Michael Sweat; Nurper Ulkuer Journal: J Health Commun Date: 2014
Authors: Linda M Richter; Bernadette Daelmans; Joan Lombardi; Jody Heymann; Florencia Lopez Boo; Jere R Behrman; Chunling Lu; Jane E Lucas; Rafael Perez-Escamilla; Tarun Dua; Zulfiqar A Bhutta; Karin Stenberg; Paul Gertler; Gary L Darmstadt Journal: Lancet Date: 2016-10-04 Impact factor: 79.321